Metraipolis › archive › dc_eaa0f6bea302

Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review — Europe PMC PMID:42357368

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42357368
DOI
10.3390/pharmaceutics18060752
License (as archived)
solo-consultazione
Archived
2026-10-19T08:08:26.204Z
SHA-256 of the archived text
cd38d002271031f62b714615f3fab488817af740cebf39278853b399912acb85
Stable URL of this page
https://metraipolis.com/documento/dc_eaa0f6bea302

How to cite

Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review — Europe PMC PMID:42357368 — Europe PMC (en), https://europepmc.org/article/MED/42357368 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eaa0f6bea302 (Metraipolis archive dc_eaa0f6bea302, sha256 cd38d002271031f62b714615f3fab488817af740cebf39278853b399912acb85)
BibTeX
@misc{dceaa0f6bea302,
  title = {Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review — Europe PMC PMID:42357368},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42357368},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eaa0f6bea302; sha256 cd38d002271031f62b714615f3fab488817af740cebf39278853b399912acb85},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42357368. Agents can read the archived copy with the MCP tool read_document.